Phase Ib/II Study of Carboplatin + M6620 + Avelumab in PARPi-resistant Ovarian Cancer
Clinical trial NCT03704467 · COMPLETED
Trial details
- NCT number
- NCT03704467
- Sponsor
- EMD Serono Research & Development Institute, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-04
- Primary completion
- 2019-11-06
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.